المؤلفون: Jaime Ramos, Joana Roseira

المصدر: Acta Médica Portuguesa, Vol 32, Iss 4, Pp 305-312 (2019)
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Agência para a Sociedade do Conhecimento (UMIC)-FCT-Sociedade da Informação
instacron:RCAAP

مصطلحات موضوعية: Certolizumab Pegol / therapeutic use, Adalimumab / pharmacokinetics, Placenta, Anti-Inflammatory Agents, lcsh:Medicine, Pregnancy Complications / drug therapy, Disease, Adrenal Cortex Hormones / therapeutic use, Inflammatory bowel disease, Infliximab / pharmacokinetics, Antibodies, Monoclonal / therapeutic use, 0302 clinical medicine, Certolizumab Pegol / pharmacokinetics, Adrenal Cortex Hormones, Pregnancy, Adalimumab / therapeutic use, Maternal-Fetal Exchange, Placenta / metabolism, lcsh:R5-920, Anti-Inflammatory Agents / therapeutic use, Tumor Necrosis Factor-alpha / antagonists & inhibitors, Antibodies, Monoclonal, General Medicine, Anti-Inflammatory Agents / pharmacokinetics, medicine.anatomical_structure, 030220 oncology & carcinogenesis, Practice Guidelines as Topic, Gestation, 030211 gastroenterology & hepatology, Female, Pregnancy Trimesters, lcsh:Medicine (General), medicine.drug, Adrenal Cortex Hormones / pharmacokinetics, medicine.medical_specialty, Inflammatory Bowel Diseases / drug therapy, Adrenal Cortex Hormones / adverse effects, 03 medical and health sciences, Internal medicine, medicine, Adalimumab, Humans, Infliximab / therapeutic use, Fetus, Tumor Necrosis Factor-alpha, business.industry, Inflammatory Bowel Disease, lcsh:R, Inflammatory Bowel Diseases, medicine.disease, Antibodies, Monoclonal / pharmacokinetics, Infliximab, CHLC GAS, Pregnancy Complications, Pregnancy Trimesters / metabolism, Certolizumab Pegol, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::586e07d2a85c618ef8ffd90a3b25f0ff
https://hdl.handle.net/10400.17/3271